Impact of concurrent androgen deprivation on fiducial marker migration in external-beam radiation therapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages

  Tiberi, David A ^a   Carrier, Jean François ^a   Beauchemin, Marie Claude ^a   Nguyen, Thu Van ^a   Béliveau Nadeau, Dominic ^a   Taussky, Daniel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION; ANDROGEN DEPRIVATION THERAPY; DIGITALLY RECONSTRUCTED RADIOGRAPHS; EXTERNAL-BEAM RADIATION THERAPY; FIDUCIAL MARKER; PLANNING CT; PROSTATE CANCERS; PROSTATE GLANDS; PROSTATE VOLUME;

DISEASES; GOLD; PATIENT MONITORING; UROLOGY;

RADIOTHERAPY;

GONADORELIN AGONIST;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FIDUCIAL MARKER; HUMAN; MALE; ORCHIECTOMY; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RADIOGRAPHY; REPRODUCIBILITY;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; COMBINED MODALITY THERAPY; FIDUCIAL MARKERS; FOREIGN-BODY MIGRATION; GOLD; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84865697733     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.016     Document Type: Article

References (22)

1. A.V. D'Amico Risk-based management of prostate cancer N Engl J Med 365 2011 169 171
2. A. Pollack, F. Ashoori, and C. Sikes The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions Int J Radiat Oncol Biol Phys 46 2000 153 158
3. M. Bolla, G. Van Tienhoven, and P. Warde External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 11 2010 1066 1073
4. C.U. Jones, D. Hunt, and D.G. McGowan Radiotherapy and short-term androgen deprivation for localized prostate cancer N Engl J Med 365 2011 107 118
5. E.M. Kerkhof, R.W. van der Put, and B.W. Raaymakers Variation in target and rectum dose due to prostate deformation: an assessment by repeated MR imaging and treatment planning Phys Med Biol 53 2008 5623 5634
6. R. Kucway, F. Vicini, and R. Huang Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy J Urol 167 2002 2443 2447
7. J.F. Langenhuijsen, E.N. van Lin, and A.L. Hoffmann Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy Urol Oncol 29 2009 52 57
8. P.W. Chung, T. Haycocks, and T. Brown On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma Int J Radiat Oncol Biol Phys 60 2004 329 334
9. G. Delouya, J.F. Carrier, and D. Beliveau-Nadeau Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer Radiother Oncol 96 2010 43 47
10. J. Pouliot, M. Aubin, and K.M. Langen (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device Int J Radiat Oncol Biol Phys 56 2003 862 866
11. P.A. Kupelian, K.M. Langen, and T.R. Willoughby Image-guided radiotherapy for localized prostate cancer: treating a moving target Semin Radiat Oncol 18 2008 58 66
12. A.M. Nichol, T. Rosewall, and C.N. Catton Intra-prostatic fiducial markers and concurrent androgen deprivation Clin Oncol 17 2005 465 468
13. A.W. Partin, L.A. Mangold, and D.M. Lamm Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 2001 843 848
14. M. Roach 3rd, C. Marquez, and H.S. Yuo Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 28 1994 33 37
15. P. Kupelian, and J.L. Meyer Image-guided, adaptive radiotherapy of prostate cancer: toward new standards of radiotherapy practice Front Radiat Ther Oncol 43 2011 344 368
16. A.M. Nichol, K.K. Brock, and G.A. Lockwood A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers Int J Radiat Oncol Biol Phys 67 2007 48 56
17. B.L. King, W.M. Butler, and G.S. Merrick Electromagnetic transponders indicate prostate size increase followed by decrease during the course of external beam radiation therapy Int J Radiat Oncol Biol Phys 79 2011 1350 1357
18. U.A. van der Heide, A.N.T.J. Kotte, and H. Dehnad Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer Radiother. Oncol 82 2007 38 45
19. P.M.A. van Haaren, A. Bel, and P. Hofman Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients Radiother Oncol 90 2009 291 298
20. G. Sanguineti, M. Marcenaro, and P. Franzone Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy Radiother Oncol 66 2003 151 157
21. H. Shirato, T. Harada, and T. Harabayashi Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy Int J Radiat Oncol Biol Phys 56 2003 240 247
22. R. Whittington, G.A. Broderick, and P. Arger The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 44 1999 1107 1110